ResearcherJohns Hopkins UniversityNo recent work listed
Alina Hasanain
Matched on OpenAlex author ID A5037649195. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 48
2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers
Papers 6
- Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000005708↗
- A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal … Co-author DOI 10.1097/sla.0000000000005710↗
- Structured CT reporting of pancreatic ductal adenocarcinoma: impact on completeness of information and interdisciplinary communication for surgical planning. First author DOI 10.1007/s00261-021-03353-9↗
- Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. Co-author DOI 10.1158/0008-5472.can-19-1523↗
- The importance of circulating and disseminated tumor cells in pancreatic cancer. Co-author DOI 10.1016/j.sopen.2019.08.002↗
- Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-0197↗
Closest collaborators
The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christopher Lee Wolfgang · 4 shared papers, 2019–2023 · strength 0.45
- Paper Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer. DOI 10.1097/sla.0000000000005708↗
- Paper The importance of circulating and disseminated tumor cells in pancreatic cancer. DOI 10.1016/j.sopen.2019.08.002↗
- Paper Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. DOI 10.1158/0008-5472.can-19-1523↗
- Ding Ding · 3 shared papers, 2019–2023 · strength 0.40
- Paper Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer. DOI 10.1097/sla.0000000000005708↗
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Ammar A. Javed · 3 shared papers, 2019–2023 · strength 0.40
- Paper Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer. DOI 10.1097/sla.0000000000005708↗
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Jing He · 2 shared papers, 2023 · strength 0.33
- Paper Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer. DOI 10.1097/sla.0000000000005708↗
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Kelly J. Lafaro · 2 shared papers, 2022–2023 · strength 0.33
- Paper Structured CT reporting of pancreatic ductal adenocarcinoma: impact on completeness of information and interdisciplinar… DOI 10.1007/s00261-021-03353-9↗
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Jin Peng He · 3 shared papers, 2019–2022 · strength 0.31
- Paper Structured CT reporting of pancreatic ductal adenocarcinoma: impact on completeness of information and interdisciplinar… DOI 10.1007/s00261-021-03353-9↗
- Paper Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. DOI 10.1158/0008-5472.can-19-1523↗
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Richard Andrew Burkhart · 3 shared papers, 2019–2023 · strength 0.29
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Paper Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. DOI 10.1158/0008-5472.can-19-1523↗
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Vincent P. Groot · 3 shared papers, 2019–2023 · strength 0.29
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Paper Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. DOI 10.1158/0008-5472.can-19-1523↗
- Paper Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-0197↗
- Amol Kumar Narang · 2 shared papers, 2019–2022 · strength 0.24
- Elliot K. Fishman · 2 shared papers, 2019–2022 · strength 0.24
- A. Floortje van Oosten · 2 shared papers, 2020–2023 · strength 0.23
- Paper A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cel… DOI 10.1097/sla.0000000000005710↗
- Paper Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. DOI 10.1158/0008-5472.can-19-1523↗
- Georgios Gemenetzis · 2 shared papers, 2019–2023 · strength 0.22
- Jun Yu · 2 shared papers, 2019 · strength 0.20
- Floortje van Oosten · 1 shared paper, 2023 · strength 0.18
- Richard A. Burkhart · 1 shared paper, 2023 · strength 0.18
- Lei Zheng · 1 shared paper, 2023 · strength 0.18
- Rubab F. Malik · 1 shared paper, 2022 · strength 0.17
- Atif Zaheer · 1 shared paper, 2022 · strength 0.17
- William R. Burns · 1 shared paper, 2023 · strength 0.15
- Joseph R. Habib · 1 shared paper, 2023 · strength 0.15
- Christopher L. Wolfgang · 1 shared paper, 2023 · strength 0.15
- Benedict Kinny‐Köster · 1 shared paper, 2023 · strength 0.15
- Michael Goggins · 2 shared papers, 2019–2020 · strength 0.14
- Barbara Aldana Blanco · 1 shared paper, 2019 · strength 0.14
- Bo Huang · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.